Justify dose modification criteria for anti-cancer drug: Authority tells GSK Susmita Roy2 Feb 2022 4:35 PM ISTNew Delhi: In line with the drug major GSK's proposal to conduct a study of anti-cancer drug Belantamab mafodotin, the Subject Expert Committee (SEC)...
DoP invites third round of applications for leftover slots under PLI Scheme Dr. Divya Colin1 Feb 2022 6:02 PM ISTNew Delhi: In order to promote domestic manufacturing of critical key starting materials (KSMs), drug intermediates (DI), and active pharmaceutical...
NPPA seeks clarifications regarding ceiling price fixation of Clotrimazole mouth paint Dr. Divya Colin31 Jan 2022 8:07 PM ISTNew Delhi: In relation to the fixation of ceiling price of antifungal drug clotrimazole 1% mouth paint, the National Pharmaceutical Pricing Authority...
Govt amends Drug Rules to include liquid antiseptic under Schedule K Dr. Divya Colin30 Jan 2022 11:30 AM ISTNew Delhi: In order to meet the huge demand for liquid antiseptics during the COVID 19 pandemic, through a recent Gazette Notification, the Ministry...
Sun Pharma gets CDSCO panel okay for phase 3 trial of Pimavanserin Dr. Divya Colin29 Jan 2022 12:51 PM ISTNew Delhi: Pharmaceutical major, Sun Pharma has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Drug makers to add SJS, TEN in package insert of Ciprofloxacin: CDSCO panel Susmita Roy28 Jan 2022 6:36 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has recommended that CDSCO may...
JB Chemicals to strike Rs 628 crore deal with Sanzyme for probiotic, reproductive brands Ruchika Sharma27 Jan 2022 1:20 PM ISTMumbai: J.B. Chemicals & Pharmaceuticals Limited (JBCPL) has recently announced that it will acquire brands for the India market from Sanzyme...
Drug Safety Alert: IPC flags adverse reactions linked to Ibuprofen Susmita Roy26 Jan 2022 11:30 AM ISTNew Delhi: The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of January, has revealed that...
USFDA halts use of Regeneron, Lilly Covid-19 antibody treatments Ruchika Sharma25 Jan 2022 11:52 AM ISTNew Delhi: The U.S. health regulator revised on Monday the emergency use authorizations for COVID-19 antibody treatments from Regeneron and Eli...
Pfizer-OPKO growth hormone deficiency treatment rejected by USFDA Farhat Nasim24 Jan 2022 6:34 PM ISTAn approval would have allowed Pfizer to compete with Ascendis Pharma (A71.F), whose once weekly growth hormone injectable was approved by the FDA in...
33 drug samples fail to clear CDSCO test, 2 declared misbranded Susmita Roy23 Jan 2022 1:15 PM ISTNew Delhi: In its latest drug safety alert, the apex drug regulatory body, the Central Drugs Standard Control Organization (CDSCO), flagged 33...
Mankind pharma Launches new critical care division Dr. Divya Colin22 Jan 2022 2:49 PM ISTThrough Saviour Mankind, the company will also Introduce certain ‘1st time in India’ products which will provide additional armamentarium for Doctors...
